Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wen-Jing Huang
FAM83A Promotes Lung Cancer Progression by Regulating the WNT and Hippo Signaling Pathways and Indicates Poor Prognosis
Frontiers in Oncology
Cancer Research
Oncology
Chinese Herbal Medicine Tangshen Formula Treatment for Type 2 Diabetic Kidney Disease in the Early Stage: Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
Related publications
Bromodomain PHD‑finger Transcription Factor Promotes Glioma Progression and Indicates Poor Prognosis
Oncology Reports
Medicine
Cancer Research
Oncology
Interleukin-33 Predicts Poor Prognosis and Promotes Ovarian Cancer Cell Growth and Metastasis Through Regulating ERK and JNK Signaling Pathways
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
B3GNT3, a Direct Target of miR-149-5p, Promotes Lung Cancer Development and Indicates Poor Prognosis of Lung Cancer
Cancer Management and Research
Oncology
Overexpression of microRNA-423-3p Indicates Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Lung Cancer
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating WNT Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of Patients
Journal of Histochemistry and Cytochemistry
Anatomy
Histology
TNFAIP8 Promotes Cell Growth by Regulating the Hippo Pathway in Epithelial Ovarian Cancer
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Low STYK1 Expression Indicates Poor Prognosis in Gastric Cancer
Cancer Management and Research
Oncology
Circ-Sox4 Promotes Non-Small Cell Lung Cancer Progression by Activating the WNT/Β-Catenin Pathway
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Capn4 Overexpression Indicates Poor Prognosis of Ovarian Cancer Patients
Journal of Cancer
Oncology
